close

Enter

Log in using OpenID

Apheresis Systems Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026

embed
The Apheresis systems market is poised to value over US$ 4 billion and grow at a CAGR of over 7% during the forecast period of 2019 to 2026.
Apheresis Systems Market Global Trends, Market Share, Industry Size, Growth,
Opportunities, and Market Forecast 2019 to 2026
The Apheresis systems market is poised to value over US$ 4 billion and grow at
a CAGR of over 7% during the forecast period of 2019 to 2026.
Membrane filtration technology and centrifugation are employed in order to
separate blood components depending upon their characteristics such as affinity for
biological elements, dimension, molecular weight, etc. Blood is drawn from the
patient’s body, combined with an anticoagulant to divide the blood components
based on detailed mechanism criteria. This followed by transfusing back the residual
of the blood to the patient’s body once the required blood component is separated.
This apheresis procedure involves sophisticated apheresis systems. Rising application
of therapeutic plasma exchange is resulting in a highly competitive market with a
large number of market players functional in apheresis systems market. The intensity
of the competition is estimated to mount significantly with the entry of new players
in the upcoming years.
Major Factors Driving the Growth of the Global Apheresis System Market:
• Increasing demand for different blood components
• Emergent complex surgeries
• Advanced novel apheresis techniques
• Increasing prevalence of diverse chronic diseases, blood-related diseases,
metabolic diseases, kidney and neurological disorders
• Availability of comprehensive database on apheresis builds based on cohort
studies, clinical trials, medical journals etc.
• Mounting demand for source plasma from biopharmaceutical companies
• Rising need to improve blood centre efficiency
• A rise in government initiatives that promote blood donations in the developing
economies
According to Cerus Corporation recent news updates implementation of pathogenreduction for all apheresis platelets collected at Navy Blood Donor Centers is well
received by the United States Department of the Navy. Thus, the global apheresis
system market is set to grow at lucrative CAGR and reach a bolstering market value
during the forecast tenure of 2019-2026.
Factors Hampering Global Apheresis Systems Market Growth
• High capital investment
• The cost associated with individual apheresis procedure and equipment
• Risk of infections
• Shortage of skilled specialists to perform Apheresis procedure
• Adoption of tailored reimbursement policies by third-party according to the
principle of appropriate
• Scarcity of qualified donors
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=180&page=requestsample
Global Apheresis Systems Market by Product Type
+ Standalone Apheresis Systems
+ Portable Apheresis Systems
+ Consumables and Supplies
Global Apheresis Systems Market by End User
+ Hospitals
+ Outpatient Centres
+ Blood Banks
Due to the rising inclination of using specific blood components to treat aliments and
rise in hospitalisations for trauma cases and chronic diseases the hospital segment is
estimated to be at the forefront in terms of market share. Also with the rising need
for blood storage centres the blood banks segment is estimated to grow with a
healthy CAGR in coming years.
Global Apheresis Systems Market by Region
+ North America
+ Latin America
+ Europe
+ Asia Pacific
+ Rest of the World
North America holds a key share in the market due to sophisticated technological
healthcare infrastructure, surge in demand for plasma-derived medicines, enhanced
patient awareness, the and rise in cases of different chronic diseases. Asia-Pacific is
estimated to be the fastest growing region owing to aggregate demand for various
blood components, increasing healthcare expenditure and rapid development in
healthcare. Untapped emerging regions from the rest of the world showcase new
growth opportunities for this market over the coming years.
Purchase a Copy of this Premium Research Report & Ask For Discount:
https://www.futurewiseresearch.com/requestsample.aspx?id=180&page=askfordiscount
Report Summary
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
FutureWise Key Takeaways
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global apheresis systems market by
product type, by end user, by region
• To cater comprehensive information on factors impacting market growth (drivers,
restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America,
Europe, Asia Pacific, Latin America, and the Middle East
• To record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and
core competencies
Table of Contents
1.1. Introduction
1.1.1.1. Scope and Objective
1.1.1.2. Assumptions and Acronyms
1.1.1.3. Forecast Factors
1.1.1.4. Research Methodology
1.2. Executive Summary
1.2.1.1. Industry Cluster Analysis
1.2.1.2. Competition Matrix
1.2.1.3. Strategies Recommendations
1.3. Market Definition
1.3.1.1. Report Scope (Inclusions & Exclusions)
1.3.1.2. Market Segmentation
1.4. Global Apheresis Systems Market Overview
1.4.1.1. Global Apheresis Systems Market Revenue (USD Mn)
1.5. Key Inclusions
1.5.1.1. Porter’s Five Force analysis
1.5.1.2. Market Dynamics
1.5.1.3. Industry Trends
1.5.1.4. Regulatory Guidelines
1.5.1.5. Opportunities in Apheresis Systems
1.6. Competition Dynamics
1.6.1.1. Company Share Analysis (2018)
1.6.1.2. Top 10 Product Pricing by Region
1.7. Global Apheresis Systems Market Revenue (USD Mn), 2018-2026 by Product
Type
1.7.1.1. Key Market Findings
1.7.1.2. Long Term ROI Segments
1.7.1.3. Revenue Opportunity Influencing Factors
1.7.1.4. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.7.1.4.1.1.
Standalone Apheresis Systems
1.7.1.4.1.2.
Portable Apheresis Systems
1.7.1.4.1.3.
Consumables and Supplies
1.8. Global Apheresis Systems Market Revenue (USD Mn), 2018-2026 by End
User
1.8.1.1. Key Market Findings
1.8.1.2. Long Term ROI Segments
1.8.1.3. Revenue Opportunity Influencing Factors
1.8.1.4. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.8.1.4.1.1.
Hospitals
1.8.1.4.1.2.
Outpatient Centres
1.8.1.4.1.3.
Blood Banks
1.9. Global Apheresis Systems Market Revenue (USD Mn), 2018-2026 by Region
1.9.1.1. Key Market Findings
1.9.1.2. Long Term ROI Segments
1.9.1.3. Revenue Opportunity Influencing Factors
1.9.1.4. Market Revenue (USD Mn) Assessment and Forecast by
Region,2026
1.9.1.4.1.1.
North America
1.9.1.4.1.2.
Latin America
1.9.1.4.1.3.
Europe
1.9.1.4.1.4.
Asia Pacific
1.9.1.4.1.5.
Rest of world
1.10.
North America Apheresis Systems Market Revenue (US$ Mn), 20182026
1.10.1.1. Key Market Findings
1.10.1.2. Long Term ROI Segments
1.10.1.3. Revenue Opportunity Influencing Factors
1.10.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.10.1.4.1.1.
US
1.10.1.4.1.2.
Canada
1.10.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.10.1.5.1.1.
Standalone Apheresis Systems
1.10.1.5.1.2.
Portable Apheresis Systems
1.10.1.5.1.3.
Consumables and Supplies
1.10.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.10.1.6.1.1.
Hospitals
1.10.1.6.1.2.
Outpatient Centres
1.10.1.6.1.3.
Blood Banks
1.11.
Latin America Apheresis Systems Market Revenue (US$ Mn), 20182026
1.11.1.1. Key Market Findings
1.11.1.2. Long Term ROI Segments
1.11.1.3. Revenue Opportunity Influencing Factors
1.11.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.11.1.4.1.1.
Brazil
1.11.1.4.1.2.
Mexico
1.11.1.4.1.3.
Argentina
1.11.1.4.1.4.
Rest of Latin America
1.11.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.11.1.5.1.1.
Standalone Apheresis Systems
1.11.1.5.1.2.
Portable Apheresis Systems
1.11.1.5.1.3.
Consumables and Supplies
1.11.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.11.1.6.1.1.
Hospitals
1.11.1.6.1.2.
Outpatient Centres
1.11.1.6.1.3.
Blood Banks
1.12.
Europe America Apheresis Systems Market Revenue (US$ Mn), 20182026
1.12.1.1. Key Market Findings
1.12.1.2. Long Term ROI Segments
1.12.1.3. Revenue Opportunity Influencing Factors
1.12.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.12.1.4.1.1.
Germany
1.12.1.4.1.2.
France
1.12.1.4.1.3.
Spain
1.12.1.4.1.4.
UK
1.12.1.4.1.5.
Russia
1.12.1.4.1.6.
Poland
1.12.1.4.1.7.
Rest of Europe
1.12.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.12.1.5.1.1.
Standalone Apheresis Systems
1.12.1.5.1.2.
Portable Apheresis Systems
1.12.1.5.1.3.
Consumables and Supplies
1.12.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.12.1.6.1.1.
Hospitals
1.12.1.6.1.2.
Outpatient Centres
1.12.1.6.1.3.
Blood Banks
1.13.
Asia Pacific America Apheresis Systems Market Revenue (US$ Mn),
2018-2026
1.13.1.1. Key Market Findings
1.13.1.2. Long Term ROI Segments
1.13.1.3. Revenue Opportunity Influencing Factors
1.13.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.13.1.4.1.1.
Emerging Asia
1.13.1.4.1.1.1.1. China
1.13.1.4.1.1.1.2. India
1.13.1.4.1.1.1.3. ASEAN-5
1.13.1.4.1.1.1.4. Rest of Emerging Asia
1.13.1.4.1.2.
Japan
1.13.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.13.1.5.1.1.
Standalone Apheresis Systems
1.13.1.5.1.2.
Portable Apheresis Systems
1.13.1.5.1.3.
Consumables and Supplies
1.13.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.13.1.6.1.1.
Hospitals
1.13.1.6.1.2.
Outpatient Centres
1.13.1.6.1.3.
Blood Banks
1.14.
Rest of World America Apheresis Systems Market Revenue (US$ Mn),
2018-2026
1.14.1.1. Key Market Findings
1.14.1.2. Long Term ROI Segments
1.14.1.3. Revenue Opportunity Influencing Factors
1.14.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.14.1.4.1.1.
Middle East
1.14.1.4.1.2.
South Africa
1.14.1.4.1.3.
North Africa
1.14.1.4.1.4.
Rest of World
1.14.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.14.1.5.1.1.
Standalone Apheresis Systems
1.14.1.5.1.2.
Portable Apheresis Systems
1.14.1.5.1.3.
Consumables and Supplies
1.14.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.14.1.6.1.1.
Hospitals
1.14.1.6.1.2.
Outpatient Centres
1.14.1.6.1.3.
Blood Banks
1.15.
Company Profiles
1.15.1.1. Competition Landscape
1.15.1.2. Global Company Share (USD Mn) Overview, 2018
1.15.1.3. Company Profiles
1.15.1.3.1.1.
TERUMO BCT, INC.
1.15.1.3.1.1.1.1. Corporate Overview
1.15.1.3.1.1.1.2. Financial Performance
1.15.1.3.1.1.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.1.1.4. Company Strategy & Channel Management
1.15.1.3.1.2.
Fresenius Kabi
1.15.1.3.1.2.1.1. Corporate Overview
1.15.1.3.1.2.1.2. Financial Performance
1.15.1.3.1.2.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.2.1.4. Company Strategy & Channel Management
1.15.1.3.1.3.
B. Braun Melsungen AG
1.15.1.3.1.3.1.1. Corporate Overview
1.15.1.3.1.3.1.2. Financial Performance
1.15.1.3.1.3.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.3.1.4. Company Strategy & Channel Management
1.15.1.3.1.4.
Asahi Kasei Medical Co., Ltd
1.15.1.3.1.4.1.1. Corporate Overview
1.15.1.3.1.4.1.2. Financial Performance
1.15.1.3.1.4.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.4.1.4. Company Strategy & Channel Management
1.15.1.3.1.5.
Delcon Medical Devices
1.15.1.3.1.5.1.1. Corporate Overview
1.15.1.3.1.5.1.2. Financial Performance
1.16.
1.15.1.3.1.5.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.5.1.4. Company Strategy & Channel Management
1.15.1.3.1.6.
Macopharma
1.15.1.3.1.6.1.1. Corporate Overview
1.15.1.3.1.6.1.2. Financial Performance
1.15.1.3.1.6.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.6.1.4. Company Strategy & Channel Management
1.15.1.3.1.7.
Grifolss
1.15.1.3.1.7.1.1. Corporate Overview
1.15.1.3.1.7.1.2. Financial Performance
1.15.1.3.1.7.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.7.1.4. Company Strategy & Channel Management
Research Sources & Primary Verbatim
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Author
Merin John
Merin John263   documents Email
Document
Category
Health and Medicine
Views
2
File Size
24 KB
Tags
system
1/--pages
Report inappropriate content